Edition:
India

Sucampo Pharmaceuticals Inc (SCMP.OQ)

SCMP.OQ on NASDAQ Stock Exchange Global Market

18.05USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$18.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
300,849
52-wk High
$18.75
52-wk Low
$9.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 61.27 0.159
Jun '17 59.90 -3.922
Mar '17 56.28 0.074
FY 2016 Dec '16 73.02 0.340
Sep '16 57.87 0.186
Jun '16 51.95 -0.019
Mar '16 47.21 -0.095
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 59.28 62.40 55.24 48.86
Quarter Ending Jun-18 3 62.61 63.93 60.70 55.47
Year Ending Dec-18 6 261.39 273.89 250.40 242.61
Earnings (per share)
Quarter Ending Mar-18 3 0.29 0.36 0.25 --
Quarter Ending Jun-18 3 0.31 0.43 0.24 --
Year Ending Dec-18 6 1.25 1.90 0.92 1.75
LT Growth Rate (%) 1 3.00 3.00 3.00 14.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 50.19 36.94 33.25
EPS (TTM) % -42.16 36.85 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sucampo Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.90%
# of Holders: 243
Total Shares Held: 36,794,662
3 Mo. Net Change: 5,410,711
# New Positions: 6
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 3
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.